Funeng Jiang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 30
- Prostate Cancer Diagnosis and Treatment 6
-
- MicroRNA in disease regulation 7
- Cancer, Lipids, and Metabolism 4
- Co-authors
- Weide Zhong (49 shared papers)Huichan He (24 shared papers)Zhaodong Han (21 shared papers)Yuxiang Liang (18 shared papers)Yanqiong Zhang (8 shared papers)Qi-Shan Dai (10 shared papers)Jianguo Zhu (14 shared papers)Yongding Wu (12 shared papers)
- Journals
- OncoTargets and Therapy (3 papers)Pathology & Oncology Research (3 papers)BioMed Research International (2 papers)International Journal of Cancer (2 papers)Medical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Funeng Jiang
62 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 80
- Cancer Research 428
- Pulmonary and Respiratory Medicine 327
- Oncology 207
- Molecular Biology 457
- Hepatology 50
Countries citing papers authored by Funeng Jiang
This map shows the geographic impact of Funeng Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funeng Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funeng Jiang more than expected).
Fields of papers citing papers by Funeng Jiang
This network shows the impact of papers produced by Funeng Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funeng Jiang. The network helps show where Funeng Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Funeng Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 108 | |
| 2 | 2013 | 89 | |
| 3 | 2014 | 64 | |
| 4 | 2023 | 62 | |
| 5 | 2016 | 59 | |
| 6 | 2018 | 59 | |
| 7 | 2020 | 54 | |
| 8 | 2016 | 51 | |
| 9 | 2014 | 48 | |
| 10 | 2014 | 46 | |
| 11 | 2018 | 44 | |
| 12 | 2013 | 43 | |
| 13 | 2013 | 43 | |
| 14 | 2011 | 41 | |
| 15 | 2014 | 41 | |
| 16 | Down-regulation of dual-specificity phosphatase 5 predicts poor prognosis of patients with prostate cancer. | 2015 | 38 |
| 17 | 2013 | 36 | |
| 18 | 2018 | 36 | |
| 19 | 2014 | 34 | |
| 20 | 2018 | 34 |
About Funeng Jiang
Funeng Jiang is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Epidemiology and Hepatology, having authored 64 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (30 papers), MicroRNA in disease regulation (7 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Autophagy in Disease and Therapy (5 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (428 citations), Pulmonary and Respiratory Medicine (327 citations), Oncology (207 citations), Molecular Biology (457 citations) and Hepatology (50 citations). Funeng Jiang has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Weide Zhong, Huichan He, Zhaodong Han, Yuxiang Liang, Yanqiong Zhang, Qi-Shan Dai, Jianguo Zhu, Yongding Wu, Chin-Lee Wu and Rujun Mo. Their work appears in journals such as OncoTargets and Therapy, Pathology & Oncology Research, BioMed Research International, International Journal of Cancer and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.